Literature DB >> 26970785

Study on the Synthesis, Characterization and Bioactivities of 3-Methyl-9'-fluorenespiro-5-hydantoin.

Petja Marinova, Marin Marinov, Maria Kazakova, Yana Feodorova, Alexander Slavchev, Denica Blazheva, Danail Georgiev, Plamen Penchev, Victoria Sarafian, Neyko Stoyanov.   

Abstract

This work describes a method for synthesis, as well as in vitro antiproliferative and antibacterial investigation of 3-methyl-9'-fluorenespiro-5-hydantoin. The structure of the substituted fluorenylspirohydantoin derivative was verified by UV-Vis, FT-IR, Raman, (1)H-NMR and (13)C-NMR spectroscopy, and by using a combination of 2D NMR experiments, which included (1)H-(1)H COSY, HMQC and HMBC sequences. The geometry of the compound was optimized by the B3LYP density functional with 6-31G(d) basis set and the (1)H and (13)C NMR spectra were predicted with the HF/6-31G(d) calculations at the optimized geometry. The anticancer activity of the 3-methyl-9'-fluorenespiro-5-hydantoin was determined in suspension cell lines originating from tumors in humans (WERI-Rb-1). The cytotoxic effect was evaluated by WST-assay (Roche Applied Science). The antimicrobial effect of the compound against Gram-negative, Gram-positive bacteria and the yeast Candida albicans was investigated.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26970785     DOI: 10.17344/acsi.2015.1591

Source DB:  PubMed          Journal:  Acta Chim Slov        ISSN: 1318-0207            Impact factor:   1.735


  2 in total

1.  Membrane-Active Hydantoin Derivatives as Antibiotic Agents.

Authors:  Ma Su; Donglin Xia; Peng Teng; Alekhya Nimmagadda; Chao Zhang; Timothy Odom; Annie Cao; Yong Hu; Jianfeng Cai
Journal:  J Med Chem       Date:  2017-10-06       Impact factor: 7.446

2.  Antiproliferative and antimigratory effects of 3-(4-substituted benzyl)-5- isopropyl-5-phenylhydantoin derivatives in human breast cancer cells.

Authors:  Ana Obradović; Miloš Matić; Branka Ognjanović; Predrag Đurđević; Emilija Marinković; Gordana Ušćumlić; Bojan Božić; Biljana Božić Nedeljković
Journal:  Saudi Pharm J       Date:  2020-01-24       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.